momelotinib,pacritinib
cti biopharma,sierra oncology
['#mpn', 'mpnsm', 'pacritinib', 'leusm', 'momelotinib']
#ash22 #mpnsm oral session. major new finding in our field : #pacritinib is also a potent #acvr1inhibitor | presented by dr #jaki #leusm #smad #hepcidin #anemia 
Executive Director-Cancer Medicine-MDACC Cancer Network | Director #BPDCN Program | Expertise: #BPDCN, Leukemia (#leusm) & MPN (#MPNSM)| Tweets:my own opinions